Topline Results of a Phase 2 Study of Subcutaneous IMVT-1401 in Patients with Generalized Myasthenia Gravis

被引：0
|
作者：
Benatar, Michael [1 ]
Breiner, Ari [2 ]
Bril, Vera [3 ]
Nowak, Richard [4 ]
Dunn, Imogene [5 ]
Jacobs, Alan [5 ]
机构：
[1] Univ Miami, Coral Gables, FL 33124 USA
[2] Ottawa Hosp, Civ Campus, Ottawa, ON, Canada
[3] Toronto Gen Hosp, Toronto, ON, Canada
[4] Yale Univ, Sch Med, New Haven, CT 06520 USA
[5] Immunovant Inc, New York, NY USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1417
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT plus Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Brauer, Edward
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    NEUROLOGY, 2022, 99 (23) : S37 - S38
  • [32] Long-term safety, and efficacy of subcutaneous Efgartigimod PH20 in patients with generalized myasthenia gravis: interim results of ADAPT-SC
    Musick, K.
    Howard, J.
    Li, G.
    Vu, T.
    Korobko, D.
    Smilowski, M.
    Liu, L.
    Steeland, S.
    Noukens, J.
    Van Hoorick, B.
    Podhorna, J.
    Li, Y.
    Utsugisawa, K.
    Sacca, F.
    Wiendl, H.
    De Bleecker, J.
    Mantegazza, R.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S179 - S179
  • [33] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Ritt, Elissa
    Howard, James F., Jr.
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan L.
    Mantegazza, Renato
    ANNALS OF NEUROLOGY, 2023, 94 : S244 - S245
  • [34] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Howard, James
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan
    Mantegazza, Renato
    NEUROLOGY, 2023, 100 (17)
  • [35] ROZANOLIXIZUMAB IN PATIENTS AGED ≥65 YEARS WITH GENERALIZED MYASTHENIA GRAVIS: A POST HOC ANALYSIS OF THE PHASE 3 MYCARING STUDY
    Vu, Tuan
    Habib, Ali A.
    Pascuzzi, Robert M.
    Sacconi, Sabrina
    Grimson, Fiona
    Pulido-Valdeolivas, Irena
    Tarancon, Thais
    Bril, Vera
    MUSCLE & NERVE, 2024, 70 (03) : 663 - 664
  • [36] Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study
    Totzeck, Andreas
    Ramakrishnan, Elakiya
    Schlag, Melina
    Stolte, Benjamin
    Kizina, Kathrin
    Bolz, Saskia
    Thimm, Andreas
    Stettner, Mark
    Marchesi, Julian R.
    Buer, Jan
    Kleinschnitz, Christoph
    Verhasselt, Hedda Luise
    Hagenacker, Tim
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [37] Autoimmune diseases associated with generalized myasthenia gravis. An observational study of 598 patients
    Gamez, J.
    Ponseti, J. M.
    Guasch, M.
    Lopez-Cano, M.
    Manuel Armengol, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 218 - 218
  • [38] ROZANOLIXIZUMAB IN GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES FROM THE RANDOMIZED PHASE 3 MYCARING STUDY
    Bril, Vera
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Boehnlein, Marion
    Bozorg, Ali
    Gayfieva, Maryam
    Woltering, Franz
    Kaminski, Henry
    MUSCLE & NERVE, 2022, 66 : S112 - S112
  • [39] COMPLIANCE TO DAILY SELF-ADMINISTERED SUBCUTANEOUS ZILUCOPLAN IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A POST HOC ANALYSIS OF THE RAISE-XT STUDY
    Ruzhansky, Katherine
    Freimer, Miriam
    Leite, M. Isabel
    Maniaol, Angelina
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vu, Tuan
    Weiss, Michael D.
    Boroojerdi, Babak
    Grimson, Fiona
    Savic, Natasa
    Howard, James F., Jr.
    MUSCLE & NERVE, 2024, 70 (03) : 590 - 591
  • [40] Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension
    Habib, Ali A.
    Druzdz, Artur
    Grosskreutz, Julian
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vu, Tuan
    Vissing, John
    Gayfieva, Maryam
    Pulido-Valdeolivas, Irene
    Tarancon, Thais
    Woltering, Franz
    Bril, Vera
    JOURNAL OF NEUROMUSCULAR DISEASES, 2025,
12345